论文部分内容阅读
色素膜炎的发病与免疫反应有密切关系。临床已普遍应用环磷酰胺、类固醇激素等免疫抑制药物治疗。最近几年对一些顽固延绵不愈的病例又从增强免疫机能方面进行探讨。但是由于药物提炼存在困难,目前临床可以较多使用的只有转移因子,眼科已有治疗病毒性角膜炎的报告。我们临床试用于色素膜炎,现将结果做一初步报告,供同道参考。临床资料转移因子是从健康人脾脏及非炎期人体扁桃体提制。用吸收260微米光测量浓度,标准均不少于7.0。临床每周肌肉注射一次。每十次为一治疗程。
Pigmented inflammation and immune response are closely related. Clinical application of cyclophosphamide, steroid hormones and other immunosuppressive drugs have generally been treated. In recent years, some stubborn cases of unhealed recovery from the immune system to explore. However, due to the difficulty of drug extraction, only the transfer factor can be used clinically nowadays, and there are reports of treatment of viral keratitis in ophthalmology. Our clinical trial for the pigmented inflammation, the results will now do a preliminary report for fellow reference. Clinical data transfer factor is extracted from healthy human spleen and non-inflammatory human tonsils. Measured by absorption of 260 microns light, the standard are not less than 7.0. Clinical intramuscular injection once a week. Every ten times for a course of treatment.